Ignite Creation Date:
2025-12-26 @ 11:12 PM
Ignite Modification Date:
2026-03-13 @ 9:53 PM
Study NCT ID:
NCT04905212
Status:
TERMINATED
Last Update Posted:
2023-12-06
First Post:
2021-05-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy
Sponsor:
RemeGen Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RC18G004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None